People with bacteriologically confirmed pulmonary tuberculosis (TB) require sputum smear monitoring at 2, 5, and 6 months to establish treatment outcomes. We retrospectively reviewed and abstracted data for 416 persons with bacteriologically confirmed pulmonary TB initiated on treatment between January 2017 and December 2019 across 11 large TB units in Masaka district in central Uganda. The dataset includes variables on health facility attributes and clinical factors. We defined complete sputum smear monitoring was measured as the receipt of three sputum smear microscopy tests at 2, 5, and 6 months of TB treatment.

We collected data for participants aged ≥15 years diagnosed with bacteriologically confirmed pulmonary TB and who were started on treatment between January 2017 and December 2019. Data were abstracted from TB unit registers used a standardized data abstraction tool, with the sequence of variables organized following that in the registers. We used trained trained research assistants to collect the data.

The variable names are written using short words and responses are indicated in a more meaningful way.